- Type I DM:
- SC 0 0.5-1 units/kg/day
- SC 0 0.5-1 units/kg/day
- Type II DM:
- SC 0 0.1-0.2 units/kg/day
Pre-filled syringe/injection: 100 units/mL
- Give 5-10min before meals
Rapid-acting insulin
It stimulates peripheral glucose uptake, inhibits hepatic glucose production, inhibits lipolysis and proteolysis regulating glucose metabolism
- Hypoglycemia
- Injection site reaction
- Injection site lipodystrophy
- Myalgia
- Pruritus
- Rash
- URI
- Weight gain
- Headache
- Peripheral edema
- Hypersensitivity reaction
- Influenza
- Hypersensitivity to components/class
- Hypoglycemia
- Pramlintide
Drug Status
| Availability | Prescription or OTC by Pharmacist |
| Pregnancy | Category B; Can be used |
| Breastfeeding | Can be used |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Novorapid Flexpen | 100 IU/mL | Pre-Filled Syringe | 5*3mL | Novo Nordisk | Phillips Therapeutics |